Allele-specific dysregulation of lipid and energy metabolism in early-stage hypertrophic cardiomyopathy.

Autor: Vaniya A; West Coast Metabolomics Center, University of California, Davis, Davis, CA, United States of America., Karlstaedt A; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America.; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America., Gulkok D; Hypertrophic Cardiomyopathy Center of Excellence, Division of Cardiology, University of California San Francisco, San Francisco, CA, United States of America., Thottakara T; Hypertrophic Cardiomyopathy Center of Excellence, Division of Cardiology, University of California San Francisco, San Francisco, CA, United States of America., Liu Y; Hypertrophic Cardiomyopathy Center of Excellence, Division of Cardiology, University of California San Francisco, San Francisco, CA, United States of America., Fan S; West Coast Metabolomics Center, University of California, Davis, Davis, CA, United States of America., Eades H; Hypertrophic Cardiomyopathy Center of Excellence, Division of Cardiology, University of California San Francisco, San Francisco, CA, United States of America., Vakrou S; Hypertrophic Cardiomyopathy Center of Excellence, Division of Cardiology, University of California San Francisco, San Francisco, CA, United States of America., Fukunaga R; Department of Biological Chemistry, Johns Hopkins University, Baltimore, MD, United States of America., Vernon HJ; McKusick Nathans Department of Genetic Medicine, Johns Hopkins University, Baltimore, MD, United States of America.; Department of Pediatrics, Johns Hopkins University, Baltimore, MD, United States of America., Fiehn O; West Coast Metabolomics Center, University of California, Davis, Davis, CA, United States of America., Roselle Abraham M; Hypertrophic Cardiomyopathy Center of Excellence, Division of Cardiology, University of California San Francisco, San Francisco, CA, United States of America.

Publikováno v: Journal of molecular and cellular cardiology plus [J Mol Cell Cardiol Plus] 2024 Jun; Vol. 8. Date of Electronic Publication: 2024 Mar 31.

Systolic blood pressure ≤110 mm Hg is associated with severe coronary microvascular ischemia and higher risk for ventricular arrhythmias in hypertrophic cardiomyopathy.

Autor: Lu DY; Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, Baltimore, Maryland.; Institute of Public Health, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Division of Cardiology, University of California San Francisco, San Francisco, California., Yalcin H; Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, Baltimore, Maryland.; Division of Cardiology, University of California San Francisco, San Francisco, California., Yalcin F; Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, Baltimore, Maryland.; Division of Cardiology, University of California San Francisco, San Francisco, California., Sivalokanathan S; Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, Baltimore, Maryland.; Division of Cardiology, University of California San Francisco, San Francisco, California., Greenland GV; Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, Baltimore, Maryland.; Division of Cardiology, University of California San Francisco, San Francisco, California., Ventoulis I; Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, Baltimore, Maryland.; Department of Occupational Therapy, University of Western Macedonia, Ptolemaida, Greece., Vakrou S; Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, Baltimore, Maryland., Pampaloni MH; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California., Zimmerman SL; Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Maryland., Valenta I; Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Maryland., Schindler TH; Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Maryland., Abraham TP; Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, Baltimore, Maryland.; Division of Cardiology, University of California San Francisco, San Francisco, California., Abraham MR; Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins University, Baltimore, Maryland.; Division of Cardiology, University of California San Francisco, San Francisco, California.

Publikováno v: Heart rhythm O2 [Heart Rhythm O2] 2023 Aug 04; Vol. 4 (9), pp. 538-548. Date of Electronic Publication: 2023 Aug 04 (Print Publication: 2023).

Cardiometabolic Syndrome: An Update on Available Mouse Models

Autor: Aravani, D. Kassi, E. Chatzigeorgiou, A. Vakrou, S.

Cardiometabolic syndrome (CMS), a disease entity characterized by abdominal obesity, insulin resistance (IR), hypertension, and hyperlipidemia, is a global epidemic with approximately 25% prevalence in adults globally. CMS is associated with increase

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::5ceff7b0a39adb71bde2afa4951bba94
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3102375

Salutary effects of the Pulvad, a novel implantable counterpulsation assist device, on cardiac mechanoenergetics

Autor: Kontogiannis, C. Aravantinos, D. Nanas, I. Kapelios, C.J. Marinakis, S. Vakrou, S. Sarchosi, S. Perrea, D.N. Mason, J.W. Nanas, J.N. Malliaras, K.

The Pressure Unloading Left Ventricular Assist Vevice (PULVAD) is a novel implantable counterpulsation LVAD, designed to provide ventricular unloading with augmentation of LV performance and retention of pulsatility. We assessed the effects of the PU

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::39374a0b74c1760b5a20c8a6d9acae25
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2981169

THE ROLE OF APELIN AND VISFATIN IN PATIENTS WITH ATRIAL FIBRILLATION

Autor: Velliou, M. Papadopoulos, D. Sanidas, E. Zerva, K. and Tsakalis, K. Vakrou, S. Iliopoulos, D. Mantzourani, M. and Perrea, D. Barbetseas, J.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::71c2715fdedf9f59bfe1c089236816fb
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3184569